Skip to main content
Top
Published in: Respiratory Research 1/2015

Open Access 01-12-2015 | Research

Tight junction disruption by cadmium in an in vitro human airway tissue model

Authors: Xuefei Cao, Haixia Lin, Levan Muskhelishvili, John Latendresse, Patricia Richter, Robert H Heflich

Published in: Respiratory Research | Issue 1/2015

Login to get access

Abstract

Background

The cadmium (Cd) present in air pollutants and cigarette smoke has the potential of causing multiple adverse health outcomes involving damage to pulmonary and cardiovascular tissue. Injury to pulmonary epithelium may include alterations in tight junction (TJ) integrity, resulting in impaired epithelial barrier function and enhanced penetration of chemicals and biomolecules. Herein, we investigated mechanisms involved in the disruption of TJ integrity by Cd exposure using an in vitro human air-liquid-interface (ALI) airway tissue model derived from normal primary human bronchial epithelial cells.

Methods

ALI cultures were exposed to noncytotoxic doses of CdCl2 basolaterally and TJ integrity was measured by Trans-Epithelial Electrical Resistance (TEER) and immunofluorescence staining with TJ markers. PCR array analysis was used to identify genes involved with TJ collapse. To explore the involvement of kinase signaling pathways, cultures were treated with CdCl2 in the presence of kinase inhibitors specific for cellular Src or Protein Kinase C (PKC).

Results

Noncytotoxic doses of CdCl2 resulted in the collapse of barrier function, as demonstrated by TEER measurements and Zonula occludens-1 (ZO-1) and occludin staining. CdCl2 exposure altered the expression of several groups of genes encoding proteins involved in TJ homeostasis. In particular, down-regulation of select junction-interacting proteins suggested that a possible mechanism for Cd toxicity involves disruption of the peripheral junctional complexes implicated in connecting membrane-bound TJ components to the actin cytoskeleton. Inhibition of kinase signaling using inhibitors specific for cellular Src or PKC preserved the integrity of TJs, possibly by preventing occludin tyrosine hyperphosphorylation, rather than reversing the down-regulation of the junction-interacting proteins.

Conclusions

Our findings indicate that acute doses of Cd likely disrupt TJ integrity in human ALI airway cultures both through occludin hyperphosphorylation via kinase activation and by direct disruption of the junction-interacting complex.
Literature
1.
go back to reference Pinot F, Kreps SE, Bachelet M, Hainaut P, Bakonyi M, Polla BS. Cadmium in the environment: sources, mechanisms of biotoxicity, and biomarkers. Rev Environ Health. 2000;15:299–323.CrossRefPubMed Pinot F, Kreps SE, Bachelet M, Hainaut P, Bakonyi M, Polla BS. Cadmium in the environment: sources, mechanisms of biotoxicity, and biomarkers. Rev Environ Health. 2000;15:299–323.CrossRefPubMed
2.
go back to reference Järup L, Berglund M, Elinder CG, Nordberg G, Vahter M. Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand J Work Environ Health. 1998;24 Suppl 1:1–52.PubMed Järup L, Berglund M, Elinder CG, Nordberg G, Vahter M. Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand J Work Environ Health. 1998;24 Suppl 1:1–52.PubMed
3.
go back to reference Richter PA, Bishop EE, Wang J, Swahn MH. Tobacco smoke exposure and levels of urinary metals in the U.S. youth and adult population: the National Health and Nutrition Examination Survey (NHANES) 1999–2004. Int J Environ Res Public Health. 2009;6:1930–46.CrossRefPubMedPubMedCentral Richter PA, Bishop EE, Wang J, Swahn MH. Tobacco smoke exposure and levels of urinary metals in the U.S. youth and adult population: the National Health and Nutrition Examination Survey (NHANES) 1999–2004. Int J Environ Res Public Health. 2009;6:1930–46.CrossRefPubMedPubMedCentral
4.
go back to reference Messner B, Bernhard D. Cadmium and cardiovascular diseases: cell biology, pathophysiology, and epidemiological relevance. Biometals. 2010;23:811–22.CrossRefPubMed Messner B, Bernhard D. Cadmium and cardiovascular diseases: cell biology, pathophysiology, and epidemiological relevance. Biometals. 2010;23:811–22.CrossRefPubMed
6.
go back to reference Waisberg M, Joseph P, Hale B, Beyersmann D. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology. 2003;192:95–117.CrossRefPubMed Waisberg M, Joseph P, Hale B, Beyersmann D. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology. 2003;192:95–117.CrossRefPubMed
7.
go back to reference Forti E, Bulgheroni A, Cetin Y, Hartung T, Jennings P, Pfaller W, et al. Characterisation of cadmium chloride induced molecular and functional alterations in airway epithelial cells. Cell Physiol Biochem. 2010;25:159–68.CrossRefPubMed Forti E, Bulgheroni A, Cetin Y, Hartung T, Jennings P, Pfaller W, et al. Characterisation of cadmium chloride induced molecular and functional alterations in airway epithelial cells. Cell Physiol Biochem. 2010;25:159–68.CrossRefPubMed
8.
go back to reference Hew KW, Heath GL, Jiwa AH, Welsh MJ. Cadmium in vivo causes disruption of tight junction-associated microfilaments in rat Sertoli cells. Biol Reprod. 1993;49:840–9.CrossRefPubMed Hew KW, Heath GL, Jiwa AH, Welsh MJ. Cadmium in vivo causes disruption of tight junction-associated microfilaments in rat Sertoli cells. Biol Reprod. 1993;49:840–9.CrossRefPubMed
9.
go back to reference Prozialeck WC, Lamar PC, Lynch SM. Cadmium alters the localization of N-cadherin, E-cadherin, and β-catenin in the proximal tubule epithelium. Toxicol Appl Pharmacol. 2003;189:180–95.CrossRefPubMed Prozialeck WC, Lamar PC, Lynch SM. Cadmium alters the localization of N-cadherin, E-cadherin, and β-catenin in the proximal tubule epithelium. Toxicol Appl Pharmacol. 2003;189:180–95.CrossRefPubMed
10.
go back to reference Siu ER, Wong EWP, Mruk DD, Sze KL, Porto CS, Cheng CY. An occludin-focal adhesion kinase protein complex at the blood-testis barrier: a study using the cadmium model. Endocrinology. 2009;150:3336–44.CrossRefPubMedPubMedCentral Siu ER, Wong EWP, Mruk DD, Sze KL, Porto CS, Cheng CY. An occludin-focal adhesion kinase protein complex at the blood-testis barrier: a study using the cadmium model. Endocrinology. 2009;150:3336–44.CrossRefPubMedPubMedCentral
11.
go back to reference Aijaz S, Balda MS, Matter K. Tight junctions: molecular architecture and function. Int Rev Cytol. 2006;248:261–98.CrossRefPubMed Aijaz S, Balda MS, Matter K. Tight junctions: molecular architecture and function. Int Rev Cytol. 2006;248:261–98.CrossRefPubMed
14.
go back to reference Blasig IE, Bellmann C, Cording J, del Vecchio G, Zwanziger D, Huber O, et al. Occludin protein family: oxidative stress and reducing conditions. Antioxid Redox Signal. 2011;15:1195–219.CrossRefPubMed Blasig IE, Bellmann C, Cording J, del Vecchio G, Zwanziger D, Huber O, et al. Occludin protein family: oxidative stress and reducing conditions. Antioxid Redox Signal. 2011;15:1195–219.CrossRefPubMed
15.
go back to reference Capaldo CT, Nusrat A. Cytokine regulation of tight junctions. Biochim Biophys Acta. 2009;1788:864–71.CrossRefPubMed Capaldo CT, Nusrat A. Cytokine regulation of tight junctions. Biochim Biophys Acta. 2009;1788:864–71.CrossRefPubMed
16.
go back to reference Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, Tsukita S, et al. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol. 1994;127:1617–26.CrossRefPubMed Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, Tsukita S, et al. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol. 1994;127:1617–26.CrossRefPubMed
17.
go back to reference Lapierre LA, Tuma PL, Navarre J, Goldenring JR, Anderson JM. VAP-33 localizes to both an intracellular vesicle population and with occludin at the tight junction. J Cell Sci. 1999;112:3723–32.PubMed Lapierre LA, Tuma PL, Navarre J, Goldenring JR, Anderson JM. VAP-33 localizes to both an intracellular vesicle population and with occludin at the tight junction. J Cell Sci. 1999;112:3723–32.PubMed
18.
go back to reference Dörfel MJ, Huber O. Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. J Biomed Biotechnol. 2012;2012:article ID 807356.CrossRef Dörfel MJ, Huber O. Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. J Biomed Biotechnol. 2012;2012:article ID 807356.CrossRef
19.
go back to reference Coyne CB, Vanhook MK, Gambling TM, Carson JL, Boucher RC, Johnson LG. Regulation of airway tight junctions by proinflammatory cytokines. Mol Biol Cell. 2002;13:3218–34.CrossRefPubMedPubMedCentral Coyne CB, Vanhook MK, Gambling TM, Carson JL, Boucher RC, Johnson LG. Regulation of airway tight junctions by proinflammatory cytokines. Mol Biol Cell. 2002;13:3218–34.CrossRefPubMedPubMedCentral
20.
go back to reference U.S Department of Health and Human Services: How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. A report of the Surgeon General. 2010 U.S Department of Health and Human Services: How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. A report of the Surgeon General. 2010
21.
go back to reference Aijaz S, D’Atri F, Citi S, Balda MS, Matter K. Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition. Dev Cell. 2005;8:777–86.CrossRefPubMed Aijaz S, D’Atri F, Citi S, Balda MS, Matter K. Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition. Dev Cell. 2005;8:777–86.CrossRefPubMed
22.
go back to reference Gonzalez-Mariscal L: Tight junctions. Landes Bioscience and Springer Science Business Media 2006 Gonzalez-Mariscal L: Tight junctions. Landes Bioscience and Springer Science Business Media 2006
23.
go back to reference Guillemot L, Hammar E, Kaister C, Ritz J, Caille D, Jond L, et al. Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression. J Cell Sci. 2004;117:5245–56.CrossRefPubMed Guillemot L, Hammar E, Kaister C, Ritz J, Caille D, Jond L, et al. Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression. J Cell Sci. 2004;117:5245–56.CrossRefPubMed
24.
go back to reference Kawabe H, Nakanishi H, Asada M, Fukuhara A, Morimoto K, Takeuchi M, et al. Pilt: a novel peripheral membrane protein at tight junctions in epithelial cells. J Biol Chem. 2001;296:48350–5. Kawabe H, Nakanishi H, Asada M, Fukuhara A, Morimoto K, Takeuchi M, et al. Pilt: a novel peripheral membrane protein at tight junctions in epithelial cells. J Biol Chem. 2001;296:48350–5.
25.
go back to reference Prozialeck WC, Niewenhuis RJ. Cadmium (Cd2+) disrupts intercellular junctions and actin filaments in LLC-PK1 cells. Toxicol Appl Pharmacol. 1991;107:81–97.CrossRefPubMed Prozialeck WC, Niewenhuis RJ. Cadmium (Cd2+) disrupts intercellular junctions and actin filaments in LLC-PK1 cells. Toxicol Appl Pharmacol. 1991;107:81–97.CrossRefPubMed
26.
go back to reference Xiao X, Mruk DD, Tang EI, Wong CKC, Lee WM, John CM, et al. Environmental toxicants perturb human Sertoli cell adhesive function via changes in F-actin organization mediated by actin regulatory proteins. Hum Reprod. 2014;29:1279–91.CrossRefPubMedPubMedCentral Xiao X, Mruk DD, Tang EI, Wong CKC, Lee WM, John CM, et al. Environmental toxicants perturb human Sertoli cell adhesive function via changes in F-actin organization mediated by actin regulatory proteins. Hum Reprod. 2014;29:1279–91.CrossRefPubMedPubMedCentral
27.
go back to reference Dokladny K, Wharton W, Ma TY, Moseley PL. Lack of cross-tolerance following heat and cadmium exposure in functional MDCK monolayers. J Appl Toxicol. 2008;28:885–94.CrossRefPubMed Dokladny K, Wharton W, Ma TY, Moseley PL. Lack of cross-tolerance following heat and cadmium exposure in functional MDCK monolayers. J Appl Toxicol. 2008;28:885–94.CrossRefPubMed
28.
go back to reference Ahmadibeni Y, Hanley M, White M, Ayrapetov M, Lin X, Sun G, et al. Metal-binding properties of a dicysteine-containing motif in protein tyrosine kinases. Chembiochem. 2007;8:1592–605.CrossRefPubMed Ahmadibeni Y, Hanley M, White M, Ayrapetov M, Lin X, Sun G, et al. Metal-binding properties of a dicysteine-containing motif in protein tyrosine kinases. Chembiochem. 2007;8:1592–605.CrossRefPubMed
30.
go back to reference Lam J, Levine SJ: The role of tyrosine kinases in the pathogenesis and treatment of lung disease. In Advances in Protein Kinases, Chapter 8. Edited by Da Silva Xavier G. InTech; 2012 Lam J, Levine SJ: The role of tyrosine kinases in the pathogenesis and treatment of lung disease. In Advances in Protein Kinases, Chapter 8. Edited by Da Silva Xavier G. InTech; 2012
31.
go back to reference Elias BC, Suzuki T, Seth A, Giorgianni F, Kale G, Shen L, et al. Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions. J Biol Chem. 2009;284:1559–69.CrossRefPubMedPubMedCentral Elias BC, Suzuki T, Seth A, Giorgianni F, Kale G, Shen L, et al. Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions. J Biol Chem. 2009;284:1559–69.CrossRefPubMedPubMedCentral
32.
go back to reference Kale G, Naren AP, Sheth P, Rao RK. Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1, ZO-2, and ZO-3. Biochem Biophys Res Commun. 2003;302:324–9.CrossRefPubMed Kale G, Naren AP, Sheth P, Rao RK. Tyrosine phosphorylation of occludin attenuates its interactions with ZO-1, ZO-2, and ZO-3. Biochem Biophys Res Commun. 2003;302:324–9.CrossRefPubMed
33.
go back to reference Basuroy S, Sheth P, Kuppuswamy D, Balasubramanian S, Ray RM, Rao RK. Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J Biol Chem. 2003;278:11916–24.CrossRefPubMed Basuroy S, Sheth P, Kuppuswamy D, Balasubramanian S, Ray RM, Rao RK. Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J Biol Chem. 2003;278:11916–24.CrossRefPubMed
34.
go back to reference Grosshans DR, Browning MD. Protein kinase C activation induces tyrosine phosphorylation of the NR2A and NR2B subunits of the NMDA receptor. J Neurochem. 2001;76:737–44.CrossRefPubMed Grosshans DR, Browning MD. Protein kinase C activation induces tyrosine phosphorylation of the NR2A and NR2B subunits of the NMDA receptor. J Neurochem. 2001;76:737–44.CrossRefPubMed
Metadata
Title
Tight junction disruption by cadmium in an in vitro human airway tissue model
Authors
Xuefei Cao
Haixia Lin
Levan Muskhelishvili
John Latendresse
Patricia Richter
Robert H Heflich
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2015
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-015-0191-9

Other articles of this Issue 1/2015

Respiratory Research 1/2015 Go to the issue

Reviewer acknowledgement

Reviewer acknowledgement 2014

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine